Over half Americans would split pills to save money; survey
More than half of Americans said they would consider splitting their prescription pills to save money if their doctor said it would not be detrimental to their health, according to the results of a national poll conducted by Opinion Research and sponsored by US insurance company UnitedHealthcare (see also Marketletter April 14).
Yet, while 57% of subjects overall would consider pill-splitting, only 9% of those currently taking medications that are safe to split are actually doing so. Respondents attributed the global economic downturn for spurring them to find ways to save money when it comes to health care and lifestyle choices.
According to the data, 27% of those surveyed currently taking medications said they are not taking their prescription medicines as directed by their physician, including 18% who said they are foregoing them altogether. Still, only about a third (31%) have asked their doctor or pharmacist about ways to save money on prescription medicines, according to the results.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze